Nov 2018

ANTG PLANS TO DOUBLE ITS WORKFORCE WITHIN MONTHS

Our CEO and founder, Matt Cantelo recently sat down with leading business publication, My Business to discuss the future of the Australian medicinal cannabis industry, ANTG’s plans for growth, the role of the industry to facilitate greater research and ANTG’s exciting partnership with Cannamedical Pharma to export Australian grown cannabis to the expanding German market. Read the article here.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >